You are here: Home > News > Latest updates & news > Allergan eye ointments recalled
Read time:


hero image

By Rhiannon Riches
Assistant Editor


Allergan has recalled certain batches of Ircal and Refresh Night Time eye ointments.

In an alert from the Department of Health’s Therapeutic Goods Administration (TGA) on 29 September, it stated that there had been reports of small particles of black plastic being ground off the lids of some ointment tubes when opening, with the potential for these particles to be introduced into the ointment.

‘If these particles were to be introduced into the eye there is the potential for discomfort, irritation, pain, swelling or abrasion,’ the TGA has warned.

The ointments are used to provide temporary relief from dry eye.

The TGA is advising health professions that if they are treating a patient who is using either Ircal or Refresh Night Time eye ointment, they should advise the patient of the recall and instruct them to check the packaging and tube for the batch number.

If a patient has ointment from one of the affected batches, health professionals should advise them to return it to the place of purchase for refund or replacement.

The affected batches are:

Ircal 2 x 3.5 g ointment

  • 86908 (expiry date 12/17)

Refresh Night Time 1 x 3.5 g ointment

  • 85422 (expiry date 06/17)
  • 86516 (expiry date 09/17)
  • 87052 (expiry date 11/17)
  • 87437 (expiry date 02/18)

Refresh Night Time 2 x 3.5 g ointment

  • 84683 (expiry date 04/17)
  • 85422 (expiry date 06/17)
  • 85432 (expiry date 06/17)
  • 86514 (expiry date 09/17)
  • 86934 (expiry date 12/17)

More information.

Filed in category: Uncategorised